Title: "The Future of Genomics: A Case for India”
Time: Thursday, 14th June, 2018 at 3:00 PM
Venue: 2nd floor, Seminar hall, IEOR Bldg.
Abstract : President Obama declared in 2013 that the US Government’s investments in Genomics had returned 140:1 to the US Economy. He launched several new programs that have now resulted in the “All of us” initiative that will sequence and record the health parameters of 1 million people in the US and will become the foundation for precision medicine. Goldman Sachs states in its April 2018 report on the Genomic Revolution that genomic medicine has a total addressable market of 4.8 trillion USD in the western world. India has already succeeded in localizing biopharmaceuticals, cinema, satellite and cellular communications, cable television, radio and computing. Can it do the same for genomic medicine?”
Bio of speaker : Vijay Chandru has three decades of experience straddling academia and industries in the US and India. A Fellow of the Indian Academies of Sciences and Engineering, Chandru is INAE distinguished technologist and professor of interdisciplinary studies at the Indian Institute of Science at Bangalore. He is the serving President of the Operational Research Society of India. In 2000 Chandru founded Strand Life Sciences, which is now the market leader in genomics and precision medicine with 15 laboratories across India. A technology pioneer of the World Economic Forum since 2006, Chandru served on the Global Agenda Council on the Future of Health from 2014-2016. He serves on the Council of Presidents of ABLE (India’s biotech industry association). Chandru is a member of Karnataka’s vision groups for Biotechnology and S&T and an honorary director of the Centre for Health Ecologies and Technology a non-profit that works for health advocacy